| Literature DB >> 27731384 |
Tingjing Zhang1, Jianqiang Liang2, Panxue Wang3, Ying Xu4, Yutang Wang1, Xinyuan Wei1, Mingtao Fan1.
Abstract
Phloretin-2'-O-glycosyltransferase (P2'GT) catalyzes the last glycosylation step in the biosynthesis of phloridzin that contributes to the flavor, color and health benefits of apples and processed apple products. In this work, a novel P2'GT of Malus x domestica (MdP2'GT) with a specific activity of 46.82 μkat/Kg protein toward phloretin and uridine diphosphate glucose (UDPG) at an optimal temperature of 30 °C and pH 8.0 was purified from the engineered Pichia pastoris broth to homogeneity by anion exchange chromatography, His-Trap affinity chromatography and gel filtration. The purified MdP2'GT was low N-glycosylated and secreted as a stable dimer with a molecular mass of 70.7 kDa in its native form. Importantly, MdP2'GT also exhibited activity towards quercetin and adenosine diphosphate glucose (ADPG), kaempferol and UDPG, quercetin and UDP-galactose, isoliquiritigenin and UDPG, and luteolin and UDPG, producing only one isoquercitrin, astragalin, hyperoside, isoliquiritin, or cynaroside, respectively. This broad spectrum of activities make MdP2'GT a promising biocatalyst for the industrial preparation of the corresponding polyphenol glycosides, preferably for their subsequent isolation and purification. Besides, MdP2'GT displayed the lowest Km and the highest kcat/Km for phloretin and UDPG compared to all previously reported P2'GTs, making MdP2'GT favor phloridzin synthesis the most.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27731384 PMCID: PMC5059724 DOI: 10.1038/srep35274
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Purification steps of recombinant MdP2′GT.
(A) (a) DEAE ion-exchange chromatography fractions and (b) their corresponding specific activity. (B) (a) SDS/PAGE analysis of Ni2+ affinity chromatography fractions (FA: mixture of F2-F4 from (A); FT: FA flow-through; E1-E11: fractions eluted by buffer C containing 5 mM, 10 mM, 20 mM, 40 mM, 60 mM, 80 mM, 100 mM, 200 mM, 300 mM, 400 mM, and 500 mM imidazole, respectively) and (b) their corresponding specific activity. (C) Further purified of E6 in (B) by G75 Superdex gel filtration (a(1)elution fractions G1-G3 from E6, a(2)elution fraction G3 purified by gel filtration again) and (b) the corresponding specific activity. (D) (1) SDS/PAGE and (2) Western Blot analysis of purified MdP2′GT, M: SuperSignal Molecular Weight Protein Ladder.
Purification and activity of MdP2′GT from the bioengineered P. pastoris GS115 supernatant.
| Purification step | Total protein (mg) | Total activity (nkat) | Specific activity (μkat/Kg protein) | [ | Yield (100%) |
|---|---|---|---|---|---|
| Crude | 1240.71 ± 50.46 | 0.14 ± 0.01 | 0.11 ± 0.01 | 1 | 1 |
| [ | 618.49 ± 31.73 | 4.01 ± 0. 18 | 6.48 ± 0.39 | 59 | 49.85 |
| Ni2+ affinity (80 mM imidazole) | 162.85 ± 18.96 | 5.40 ± 0.34 | 33.13 ± 1.23 | 301 | 13.13 |
| Gel filtration (Superdex 75) | 111.89 ± 8.93 | 4.53 ± 0.37 | 40.45 ± 2.01 | 368 | 9.02 |
aDetermined data represents the pooled fractions of F2, F3, and F4 that displayed the highest specific activity in Fig. 1A.
bCalculated according to the mean of the specific activity and expressed as an integer.
Figure 2Molecular weight and glycosylation analysis.
(A) SEC of marker proteins (1, 75 kDa conalbumin, 67 kDa bovine serum albumin, 45 kDa egg albumins, 29 kDa carbonic anhydrase, and 14.9 kDa lysozyme), native MdP2′GT (2, calculated MW 70.7 kDa), native (3, calculated MW 65.3 kDa) and denatured (4, calculated MW 35.2 kDa and 24.9 kDa) deglycosylated MdP2′GT with PNGase F, and native (5, calculated MW 65 kDa) and denatured (6, calculated MW 24.5 kDa) deglycosylated MdP2′GT with Endo H. (B) The calibration curve of the marker proteins. (C) SDS-PAGE analysis of (1) native MdP2′GT, (2) native and (3) denatured deglycosylated MdP2′GT with PNGase F, (4) 1 U PNGase F, (5) native and (6) denatured deglycosylation MdP2′GT with Endo H, and (7)10 U of Endo H. The specific activity of the native and native deglycosylated MdP2′GT under optimal conditions are indicated near the respective lanes. (D) MALDI-TOF spectra of (1)the native, (2)the native deglycosylated MdP2′GT with PNGase F or Endo H, and denatured deglycosylated MdP2′GT with (3)PNGase F or (4)Endo H.
Figure 3Effects of pH and temperature on enzyme activity and stability.
(A) Effect and optimum pH. (B) pH stability. (C) Effect and optimum temperature. (D) Temperature stability.
Figure 4Structural formulas of the glycosides synthesized by MdP2′GT.
Figure 5Structural analysis of MdP2′GT.
(A) Ribbon diagram of the MdP2′GT homology-based structure with the N-terminal domain (red), C- terminal domain (green), interdomain liker region (blue), and the PSPG motif (cyan). (B) Overlay of the UDPG/phloretin complex with MdP2′GT. (C) Overlay of the inhibitor (UDP) with MdP2′GT.
Effects of various reagents on purified MdP2′GT activity.
| Addition | Concentration/(mM) | Relative activity/(100%) | IC50/(mM) |
|---|---|---|---|
| None | — | 100 | — |
| NaCl | 500 | 100 ± 1.00 | ND |
| KCl | 5 | 99.58 ± 2.31 | ND |
| MgCl2 | 2 | 130.35 ± 3.53 | Activator |
| NiCl2 | 5 | 98.26 ± 2.08 | ND |
| CoCl2 | 5 | 0.00 ± 0.00 | 0.05 ± 0.01 |
| CuCl2 | 5 | 0.00 ± 0.00 | 0.01 ± 0.01 |
| CaCl2 | 5 | 54.21 ± 1.05 | 5.50 ± 0.12 |
| BaCl2 | 5 | 99.03 ± 2.54 | ND |
| MnSO4 | 5 | 47.41 ± 1.13 | 4.50 ± 0.11 |
| FeSO4 | 5 | 119.43 ± 3.61 | Activator |
| AlCl3 | 5 | 67.81 ± 1.03 | 8.00 ± 0.50 |
| FeCl3 | 5 | 60.78 ± 1.01 | 6.50 ± 0.23 |
| EDTA | 5 | 99.16 ± 2.21 | ND |
| Glycerol | 686 | 98.13 ± 2.15 | ND |
| AEBSF | 0.5 | 99.51 ± 2.36 | ND |
| β-mercaptoethanol | 5 | 99.02 ± 1.47 | ND |
| Dithiothreitol | 5 | 99.15 ± 1.43 | ND |
| Methanol | 1236 | 99.23 ± 1.41 | ND |
| Dimethyl sulfoxide | 704 | 99.54 ± 1.40 | ND |
| 1 | 18.45 ± 1.02 | 0.24 ± 0.07 | |
| 1 | 20.53 ± 1.08 | 0.28 ± 0.01 | |
| UDP | 5 | 0 ± 0.00 | 0.10 ± 0.01 |
| UTP | 5 | 3.05 ± 0.26 | 2.5 ± 0.10 |
| UMP | 5 | 38.25 ± 1.07 | 4.00 ± 0.13 |
| Uridine | 5 | 98.17 ± 2.12 | ND |
| Trilobatin | 5 | 21.70 ± 1.15 | 3.00 ± 0.21 |
| 3- hydroxyphloridzin | 5 | 15.65 ± 0.58 | 2.50 ± 0.20 |
Relative activities were calculated by comparison to a control in which none is added.
No effect of addition on MdP2′GT activity was defined as relative activities ≥95%.
ND: no effects detected at selected concentrations.
Activator: additions increased MdP2′GT activity at selected concentrations.
Analytical data of formed glycosides in the other five donor/acceptor combinations with purified MdP2′GT.
| Donor/acceptor combinations | Glycosides | Rt (min) | m/z [M-H+] | NMR (500 MHz, DMSO- | |
|---|---|---|---|---|---|
| δ1H (ppm) | δ13C (ppm) | ||||
| UDPG/Isoliquiritigenin | 1 | 30.43 | 417.118 | 8.009 (1H, d, J = 8.8 Hz, H-6′), 7.837 (1H, d, J = 15.5 Hz, H-8), 7.806 (2H, d, J = 8.0, H-2,6), 7.720 (1H, d, J = 15.3 Hz, H-7), 7.182 (2H, d, J = 8.7 Hz, H-3,5), 6.438 (1H, dd, J = 2.0, 8.5 Hz, H-5′), 6.314 (1H, d, J = 2.0 Hz, H-3′), 5.011 (1H, d, J = 7.2 Hz, H-1″), 4.013 (1H, dd, J = 2.0, 11.8 Hz, H-6″), 3.745 (1H, dd, J = 5.3, 11.9 Hz, H-6″) | 191.97 (C-9), 166.19 (C-4′), 165.16 (C-2′), 159.66 (C-4), 143.43 (C-8), 132.10 (C-6′), 130.02 (C-2,6), 129.13 (C-1), 118.65 (C-7), 116.60 (C-3,5), 113.28 (C-1′), 107.85 (C-5′), 102.43 (C-3′), 100.41 (C-1″), 76.86 (C-3″), 76.55 (C-5″), 73.44 (C-2″), 69.90 (C-4″), 61.07 (C-6″) |
| UDPG/Kaempferol | 2 | 30.54 | 447.092 | 7.949 (2H, d, J = 9.0 Hz, H-2′, 6′), 6.798 (2H, d, J = 8.5 Hz, H-3′, 5′), 6.295 (1H, d, J = 2.0 Hz, H-8), 6.110 (1H, d, J = 2.0 Hz, H-6), 5.113 (1H, d, J = 7.0 Hz, H-1″), 3.088-3.573 (6H, m, sugar protons) | 178.15 (C-4), 164.62 (C-7), 161.67 (C-5), 160.15 (C-4′), 157.81 (C-9), 157.14 (C-2), 134.18 (C-3), 130.87 (C-2′, 6′), 121.49 (C-1′), 114.71 (C-3′, 5′), 104.40 (C-10), 102.97 (C-1″), 98.58 (C-6), 93.43 (C-8), 76.97 (C-5″), 76.72 (C-3″), 74.38 (C-2″), 70.09 (C-4″), 61.37 (C-6″) |
| ADPG/Quercetin | 3 | 28.81 | 463.087 | 7.502 (1H, dd, J = 7.5, 2.5 Hz, H-6′), 7.497 (1H, d, J = 2.4 Hz, H-2′), 6.774 (1H, d, J = 7.0 Hz, H-5′), 6.326 (1H, d, J = 2.1 Hz, H-8), 6.120 (1H, d, J = 2.0 Hz, H-6), 5.194 (1H, d, J = 7.4 Hz, H-1″) | 177.97 (C-4), 164.46 (C-7), 161.49 (C-5), 157.09 (C-2), 156.89 (C-9), 148.46 (C-4′), 144.46 (C-3′), 134.15 (C-3), 121.60 (C-6′), 121.46 (C-1′), 116.35 (C-5′), 114.88 (C-2′), 104.20 (C-10), 103.40 (C-1″), 98.51 (C-6), 93.38 (C-8), 75.80 (C-5″), 73.55 (C-3″), 71.64 (C-2″), 68.48 (C-4″), 60.47 (C-6″) |
| UDP-Gal/Quercetin | 4 | 28.75 | 463.091 | 7.491 (2H, dd, J = 7.8, 2.0 Hz, H-2′,6′), 6.773 (1H, d, J = 7.8 Hz, H-5′), 6.278 (1H, d, J = 2.0 Hz, H-8), 6.091 (1H, d, J = 2.0 Hz, H-6), 5.271 (1H, d, J = 7.3 Hz, H-1″), 3.706-3.285 (6H, m, sugar protons) | 177.61 (C-4), 164.17 (C-7), 161.17 (C-5), 157.13 (C-2), 156.58 (C-9), 147.98 (C-4′), 144.03 (C-3′), 133.75 (C-3), 121.34 (C-6′), 121.20 (C-1′), 115.71 (C-5′), 114.13 (C-2′), 103.81 (C-10), 102.46 (C-1″), 98.03 (C-6), 92.85 (C-8), 76.52 (C-5″), 76.25 (C-3″), 73.87 (C-2″), 69.34 (C-4″), 60.68 (C-6″) |
| UDPG/Luteolin | 5 | 27.60 | 447.092 | 7.41 (1H, d, J = 2.4 Hz, H-2′), 7.35 (1H, dd, J = 8.4, 2.4 Hz, H-6′), 6.89 (1H, d, J = 8.4 Hz, H-5′), 6.77 (1H, d, J = 2.4 Hz, H-8), 6.75 (1H, s, H-3), 6.43 (1H, d, J = 2.4 Hz, H-6), 5.07 (1H, d, J = 7.2 Hz, H-1″) | 181.68 (C-4), 164.34 (C-2), 162.60 (C-7), 160.72 (C-5), 156.75 (C-9), 149.10 (C-4′), 145.05 (C-3′), 121.37 (C-1′), 118.53 (C-6′), 115.07 (C-2′), 112.50 (C-5′), 105.01 (C-10), 102.47 (C-3), 99.59 (C-6), 99.01 (C-1″), 94.10 (C-8), 76.47 (C-3″), 75.81 (C-5″), 72.68 (C-2″), 69.14 (C-4″), 60.29 (C-6″) |
| [ | 6 | 28.04 | 437.256 | 2.79 (2H, t, J = 7.4 Hz, H-7), 3.03 (2H, dd, J = 11.4 Hz, H-2″, 4″), 3.11 (1H, m, J = 5.1 Hz, H-5′′), 3.20 (1H, m, J = 4.7 Hz, H-3″), 3.38 (2H, m, J = 8.3 Hz, H-8), 3.62 (2H, dd, J = 5.4, 11.8 Hz, H-6″), 4.94 (1H, d, J = 6.8 Hz, H-1″), 5.86 (2H, d, J = 1.9 Hz, H-3, 5), 6.08 (1H, d, J = 1.8 Hz, H-3′), 6.59 (2H, d, J = 8.1 Hz, H-2, 6), 6.95 (1H, d, J = 8.4 Hz, H-5′) | 29.43 (C-7), 45.56 (C-8), 61.02 (C-6″), 69.68 (C-4″), 73.30 (C-2″), 77.00 (C-5″), 77.08 (C-3″), 94.05 (C-5′), 96.96 (C-3′), 100.66 (C-1″), 105.37 (C-1′), 114.68 (C-2 and C-6), 128.99 (C-3 and C-5), 132.48 (C-1), 154.97 (C-4), 160.91 (C-4′), 164.58 (C-6′), 166.16 (C-2′), 205.14 (C-9) |
aThe formed glycoside in UDPG/Phloretin and ADPG/Phloretin combinations was determined in our previous unpunished study and identified as phloridzin.
Enzyme characters and kinetic parameters of purified MdP2′GT.
| Donor/acceptor combinations | Acceptor class | Products | Donors | Acceptors | Specific activity (μkat/Kg protein) | pH optimum | Temperature optimum (°C) | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Km (μM) | kcat (s−1) | kcat/Km (s−1. μM−1) | Km (μM) | kcat (s−1) | kcat/Km (s−1. μM−1) | ||||||
| UDPG/Phloretin | Dihydrochalcone | Phloridzin | 7.53 ± 1.35 | 21.33 ± 0.68 | 2.83 | 0.50 ± 0.02 | 9.87 ± 0.89 | 19.73 | 46.82 ± 3.45 | 8.0 | 30 |
| ADPG/Phloretin | Dihydrochalcone | Phloridzin | 58.67 ± 5.63 | 4.65 ± 0.14 | 0.08 | 4.09 ± 0.14 | 2.95 ± 0.10 | 0.72 | 4.90 ± 0.98 | 8.0 | 30 |
| UDPG/Isoliquiritigenin | Chalcone | Isoliquiritin | 36.19 ± 4.09 | 8.68 ± 0.26 | 0.24 | 2.40 ± 0.08 | 4.35 ± 0.15 | 1.81 | 10.37 ± 1.56 | 7.5 | 40 |
| UDPG/Kaempferol | Flavonol | Astragaline | 30.43 ± 3.11 | 10.83 ± 0.47 | 0.36 | 2.09 ± 0.12 | 5.65 ± 0.65 | 2.70 | 17.13 ± 1.43 | 8.5 | 35 |
| ADPG/Quercetin | Flavonol | Isoquercitrin | 14.57 ± 2.45 | 15.22 ± 0.56 | 1.04 | 1.06 ± 0.08 | 7.41 ± 0.70 | 6.99 | 32.18 ± 2.95 | 8.5 | 35 |
| UDP-Gal/Quercetin | Flavonol | Hyperoside | 26.19 ± 3.23 | 13.18 ± 0.52 | 0.50 | 1.81 ± 0.10 | 6.18 ± 0.23 | 5.24 | 23.13 ± 2.03 | 8.0 | 35 |
| UDPG/Luteolin | Flavone | Cynaroside | 42.59 ± 4.81 | 5.95 ± 0.09 | 0.14 | 2.89 ± 0.18 | 3.24 ± 0.18 | 1.12 | 7.80 ± 1.13 | 7.5 | 40 |
Enzyme characters and Kinetic parameters of MdP2′GT and reported P2′GTs.
| Enzyme | [ | [ | [ | [ | [ | [ | Substrate specificity (Donor/acceptor combinations) | Organisms | References |
|---|---|---|---|---|---|---|---|---|---|
| 0.50 | 9.87 | 19.74 | 167.21 | 8.0 | 30 | UDPG/Phloretin, ADPG/Phloretin, UDPG/Isoliquiritigenin, UDPG/Kaempferol, ADPG/Quercetin, UDP-Gal/ Quercetin, and UDPG/Luteolin | This study | ||
| UGT88F1 | 0.62 | 9.72[ | 15.68 | 164.75[ | 7.7 | 25 | UDPG/Phloretin, UDP-galactose/ Phloretin | ||
| UGT88F2 | — | — | — | — | 8.0 | 45 | UDPG/Phloretin, UDP/Phloridzin | ||
| UGT71A15 | 82 | 0.42[ | 0.005 | 8 × 10−3 | 6.75 | 30 | UDPG/Phloretin, UDPG/Naringenin chalcone, UDPG/Eriodictyol chalcone, UDPG/Isoliquiritigenin, UDPG/Butein, UDPG/Naringenin, UDPG/Eriodictyol, UDPG/Luteolin, UDPG/Kaempferol, and UDPG/Quercetin | ||
| UGT71K1 | — | — | — | — | 6.75 | 40 | UDPG/Phloretin, UDPG/Kaempferol, UDPG/Quercetin, UDPG/Isoliquiritigenin, UDPG/Butein | ||
| UGT71K2 | — | — | — | — | 6.25 | 25 | UDPG/Phloretin, UDPG/Kaempferol, UDPG/Quercetin, UDPG/Isoliquiritigenin, UDPG/Butein | ||
| UGT71A16 | — | — | — | — | 6.75 | 30 | UDPG/Phloretin, UDPG/Eriodictyol, UDPG/Apigenin, UDPG/Luteolin, and UDPG/Caffeic acid | ||
| [ | — | — | — | — | 8.0 | 30 | UDPG/Phloretin, UDPG/geldanamycin analogs | ||
| DicGT4 | — | — | — | — | 6.0 | 30 | UDPG/Phloretin, UDPG/Naringenin, UDPG/Kaempferol, UDPG/Quercetin, UDPG/apigenin, and UDPG/cyanidin |
aData was determined for the glycosylation of 2′-OH group on phloretin using the UDPG/Phloretin combination as substrate.
bCalculated according to the turnover rate of 9.72 × 10−4 mol.s−1.mol−1 and MW = 59 kDa.
cCalculated according to Km and MW = 59 kDa.
dCalculated according to Km and MW = 52 kDa.
eGeldanamycin analogs act as the acceptors of YjiC included 18-dehydroxy-17-demethoxyreblastatin, 18-dehydroxy-17-O-demethylreblastatin, 18-dehydroxy-17-O-demethyl-4,5-dehydroreblastatin, 17-demethoxy-reblastatin, and 7-demethoxy-15-hydroxylreblastatin.
Figure 6Structural formulas of the polyphenols acting as the acceptors of MdP2′GT.
Amino acid sequence identity (I) and similarity (S) of MdP2′GT and other reported P2′GTs.
| Enzyme | UGT88F1 | UGT88F2 | UGT71A15 | UGT71K1 | UGT71K2 | UGT71A16 | YjiC | DicGT4 | References |
|---|---|---|---|---|---|---|---|---|---|
| UGT88F2 | |||||||||
| UGT71A15 | I: 34.3% S: 50.9% | ||||||||
| UGT71K1 | I: 36.1% S: 53.6% | ||||||||
| UGT71K2 | I: 35.8% S: 53.0% | I: 45.8% S: 67.0% | |||||||
| UGT71A16 | I: 34.4% S: 51.0% | I: 45.1% S: 66.6% | |||||||
| [ | I: 14.2% S: 46.7% | I: 14.2% S: 46.7% | I: 16.8% S: 44.4% | I: 15.7% S: 45.2% | I: 15.7% S: 45.2% | I: 16.4% S: 45.5% | |||
| [ | I: 27.1% S: 42.3% | I: 27.3% S: 42.3% | I: 26.5% S: 41.4% | I: 27.0% S: 39.1% | I: 26.8% S: 39.4% | I: 26.5% S: 43.1% | I: 20.2% S: 48.2% | ||
| [ | I: 33.6% S: 35.0% | I: 31.8% S: 37.1% | I: 13.2% S: 26.6% | I: 27.1% S: 33.1% | This study |
Values for orthologous sequences are highlighted in bold; those for paralogous sequences are in italics.
aCalculated according to the sequences of YjiC following the method described as Gosch et al.20.
bCalculated according to the sequences of DicGT4 following the method described as Gosch et al.20.
cCalculated according to the sequences of MdP2′GT shown in Fig. S1 following the method described as Gosch et al.20.